[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356717-105":59,"doc-detail-356717-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","a-harmless-to-harmful-switchable-and-spatiotemporally-activated-nano-crispr-hierarchically-amplifies-ferroptosis-in-melanoma","A harmless-to-harmful switchable and spatiotemporally activated nano-CRISPR hierarchically amplifies ferroptosis in melanoma","","Ferroptosis therapy is limited by insufficient lipid peroxide (LPO) and tight cellular regulation. Gong et al. introduce ARCHER, a switchable, spatiotemporally activated nano-CRISPR that targets cancer cells and, under tumor-specific conditions plus laser irradiation, sequentially amplifies ferroptosis sensitivity by suppressing GPX4, elevating iron ions, and increasing reactive oxygen species (ROS). GPX4 downregulation primes cells for LPO accumulation, while Ce6Fe(III)Cl activation produces cytotoxic Fe(III) and Ce6-derived ROS to drive a ferroptosis storm, achieving 60% tumor ablation with minimal off-target effects in vivo.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-harmless-to-harmful-switchable-and-spatiotemporally-activated-nano-crispr-hierarchically-amplifies-ferroptosis-in-melanoma/356717/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-harmless-to-harmful-switchable-and-spatiotemporally-activated-nano-crispr-hierarchically-amplifies-ferroptosis-in-melanoma/356717.png","ImageObject",300,407,{"name":92,"@type":93},"Sarah ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is ARCHER, and what problem does it address in ferroptosis therapy?","Question",{"text":112,"@type":113},"ARCHER is a switchable, spatiotemporally activated nano-CRISPR system designed to improve ferroptosis therapy efficiency by overcoming low LPO levels and homeostatic regulation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does ARCHER work under tumor-specific conditions?",{"text":117,"@type":113},"ARCHER targets cancer cells and responds to tumor acidity and hyaluronidase release to deliver CRISPR-Cas9 and Ce6Fe(III)Cl, sustaining GPX4 suppression and triggering Fe(III)/ROS generation after laser irradiation.",{"name":119,"@type":110,"acceptedAnswer":120},"What therapeutic outcomes were reported in vivo?",{"text":121,"@type":113},"In vivo results show about 60% tumor ablation with minimal off-target effects, supporting strong therapeutic efficacy for ferroptosis-driven cancer treatment.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356717,1790211839,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},962085320529,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Article  \nA harmless-to-harmful switchable and spatiotemporally activated nano-CRISPR hierarchically amplifies ferroptosis in melanoma  \nGraphical abstract  \nHighlights  \n• ARCHER is spatiotemporally activated in cancer cells  \n• ARCHER selectively induces ferroptosis in cancer cells  \n• ARCHER permanently augments ferroptosis sensitivity in cancer cells  \n• ARCHER inhibits tumors growth with minimal adverse effects  \nAuthors  \nChunqing Ou, Xianzhou Huang, Dongxue Huang, ..., Xinyue Wu, Qinjie Wu, Changyang Gong  \nCorrespondence  \n[cellwqj@163.com](cellwqj@163.com) (Q.W.),  \n[chygong14@163.com](chygong14@163.com) (C.G.)  \nIn brief  \nGong et al. develop ARCHER, a switchable and spatiotemporally activated nano-CRISPR system. Under tumor-specific conditions and laser irradiation, ARCHER sequentially amplifies ferroptosis sensitivity via CRISPR/Cas9-mediated GPX4 suppression, iron ions, and ROS, which triggers a synergistic ferroptosis storm, achieving 60% tumor ablation with minimal off-target effects in vivo.  \nOu et al., 2026, Cell Reports Medicine 7, 102718  \nApril 21, 2026 © 2026 The Authors. Published by Elsevier Inc.  \n[https://doi.org/10.1016/j.xcrm.2026.102718](https://doi.org/10.1016/j.xcrm.2026.102718)  \nll  \nll  \nOPEN ACCESS  \nArticle  \nA harmless-to-harmful switchable and spatiotemporally activated nano-CRISPR hierarchically amplifies ferroptosis in melanoma  \nChunqing Ou,1,2,3 Xianzhou Huang,1,3 Dongxue Huang,1,3 Rui Luo,1 Ruhan Chen,1 Xinchao Li,1 Xinyue Wu,1 Qinjie Wu,1,* and Changyang Gong1,4,*  \n1Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China  \n2Department of Gastroenterology, Shanghai Institute of Pancreatic Diseases, Changhai Hospital, National Key Laboratory of Immunity and Inflammation, Naval Medical University, Shanghai 200433, China  \n3These authors contributed equally  \n4Lead contact  \n*Correspondence: [cellwqj@163.com](cellwqj@163.com) (Q.W.), [chygong14@163.com](chygong14@163.com) (C.G.) [https://doi.org/10.1016/j.xcrm.2026.102718](https://doi.org/10.1016/j.xcrm.2026.102718)  \nSUMMARY  \nFerroptosis therapy faces challenges due to low lipid peroxide (LPO) levels. Herein, we develop a harmlessto-harmful switchable and spatiotemporally activated nano-CRISPR system (termed ARCHER) that sequentially amplifies ferroptosis sensitivity, iron ion levels, and reactive oxygen species (ROS) to amplify ferroptosis therapy efficiency. ARCHER targets cancer cells and releases CRISPR-Cas9 and Ce6Fe(III)Cl in response tohyaluronidase and tumor acidity. CRISPR-Cas9 sustains effective suppression of LPO-reducing protein GPX4 . By persistently enhancing LPO accumulation through GPX4 downregulation, ARCHER primes cancer cells for ferroptosis and sensitizes them to subsequent interventions. Upon laser irradiation under acidic conditions, Ce6Fe(III)Cl undergoes spatiotemporal activation, transforming from inert form into cytotoxic Fe(III) ions and Ce6-generated ROS. Liberated Fe(III) and ROS synergistically amplify lipid peroxidation, driving LPO accumulation to trigger ferroptosis storm in sensitized cancer cells. In vivo studies demonstrated that ARCHER achieves 60%(3/5) tumor ablation with minimal off-target effects, validating its high therapeutic efficacy in ferroptosis-driven cancer treatment.  \nINTRODUCTION  \nFerroptosis, an iron-dependent cell death form, has sparked great interest in treatment of cancer, which is caused by lipid membrane rupture due to the overwhelming accumulation of lipid peroxide (LPO) .1–4 Ferroptosis heavily relies on the intracellular iron ion level and the reactive oxygen species (ROS) level.5 ,6 The iron-mediated Fenton reaction converts endogenous H2O2 to highly toxic ROS, and ROS then oxidize lipids to generate LPO to rupture the lipid membrane, resulting in ferroptosis.7–10 Thus, iron ion supplementation and ROS generation to increase LPO production have been developed to induce cancer ferroptosi","cbCaiqx4zaQiNAPZ","https://ap.wps.com/l/cbCaiqx4zaQiNAPZ","pdf",14716836,"English","# Highlights\n# In brief\n# SUMMARY\n# INTRODUCTION","[{\"question\":\"What is ARCHER, and what problem does it address in ferroptosis therapy?\",\"answer\":\"ARCHER is a switchable, spatiotemporally activated nano-CRISPR system designed to improve ferroptosis therapy efficiency by overcoming low LPO levels and homeostatic regulation.\"},{\"question\":\"How does ARCHER work under tumor-specific conditions?\",\"answer\":\"ARCHER targets cancer cells and responds to tumor acidity and hyaluronidase release to deliver CRISPR-Cas9 and Ce6Fe(III)Cl, sustaining GPX4 suppression and triggering Fe(III)/ROS generation after laser irradiation.\"},{\"question\":\"What therapeutic outcomes were reported in vivo?\",\"answer\":\"In vivo results show about 60% tumor ablation with minimal off-target effects, supporting strong therapeutic efficacy for ferroptosis-driven cancer treatment.\"}]","A harmless-to-harmful switchable and spatiotemporally activated nano-CRISPR hierarchically amplifies ferroptosis in melanoma | PDF",1790126919,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/78bff1709b29c7a2481de73f96680a86.webp",983,1276,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f3b5a2961004970e4d1dae54d55e2010.webp",982,1275,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/10a49589d938c596105f77aa7c9972ff.webp",981,1273,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eec77677e4fec9a374f9180a3a3dd60f.webp",980,1272]